This session explores how Australia can transform obesity's designation as a national health priority into concrete outcomes through strategic policy reform, sustainable funding models, and coordinated leadership across healthcare, government, and community sectors.
Addresses the challenge of expanding bariatric surgery capacity amid workforce shortages and surging demand, exploring innovative surgical approaches, training pathways, and system redesign to maintain safety standards while improving equitable access.
Fast, focused, and energising — speed networking is your chance to meet fellow attendees, exchange ideas, and spark new collaborations with your metabolic healthcare professionals
This session examines how breakthrough GLP-1 receptor agonists and novel combination therapies are transforming obesity treatment paradigms, elevating patient outcomes, reshaping clinical expectations, and establishing obesity as a medically manageable chronic disease requiring long-term pharmaceutical intervention.
Fuel up, connect, and explore - your chance to grab a coffee, meet solution partners, and spark new conversations across Australia’s obesity care community
Refuel, reconnect, and recharge — take this opportunity to meet peers from across Australia’s health, research, and policy community, exchange ideas, and spark fresh conversations shaping the future of obesity and metabolic health.
This session unpacks the National Heart Foundation of Australia’s clinical consensus on the link between obesity and cardiovascular disease. It highlights what the guidance means for prevention, risk assessment, and patient management in real-world settings.
Key Takeaways:
• Obesity should be managed as a key cardiovascular risk factor, not just a lifestyle issue.
• The consensus provides clear, evidence-based direction to support earlier and more consistent clinical intervention.
Menopause brings more than visible symptoms. It triggers deep hormonal shifts that affect metabolism, heart health, and long-term disease risk. Changes in oestrogen, insulin sensitivity, and cortisol levels interact to increase the risk of weight gain, diabetes, cardiovascular disease, and inflammation. Understanding these changes early allows women to take practical steps to protect their health through targeted lifestyle and clinical strategies.
Key Takeaways:
• Oestrogen decline directly impacts fat distribution, cholesterol, and insulin sensitivity.
• Insulin resistance often increases during menopause, raising diabetes risk.
• Cortisol dysregulation can worsen stress, sleep, and central weight gain.
• Early, hormone-aware lifestyle and medical strategies can significantly reduce long-term cardiometabolic risk.
This session Provides clinical insights into the complex management of obesity throughout reproductive stages, examining evidence-based approaches for weight optimisation during preconception, fertility treatments, pregnancy, and postpartum periods while balancing maternal-fetal health outcomes.
Key Takeaways:
• Understanding how obesity affects fertility, ovulation, pregnancy complications, and metabolic health, plus strategies for safe preconception weight management and timing interventions to improve conception rates and pregnancy outcomes.
• Navigating appropriate gestational weight gain targets, managing obesity-related pregnancy complications, addressing postpartum weight retention, and safely integrating pharmacological or surgical interventions across different reproductive stages without compromising maternal or infant health.
Explore how evidence-based digital health platforms can deliver scalable behavioral interventions for obesity management, examining the practical challenges of clinical integration, reimbursement models, patient engagement sustainability, and measuring real-world effectiveness beyond controlled trials.
Examine the integration of artificial intelligence tools into obesity and metabolic care, addressing clinical validation requirements, algorithmic transparency, workflow implementation, ethical considerations, and strategies for ensuring AI enhances rather than replaces clinical judgment.
Explore how predictive analytics and machine learning models identify individuals at high risk for obesity and metabolic disease before clinical manifestation, enabling proactive, targeted interventions that shift healthcare from reactive treatment to preventive population health management.
Engage with technology demos, explore transformative products, and discover how these innovations can enhance patient care and streamline healthcare delivery across ANZ
Fuel up, connect, and explore — your chance to grab a coffee, meet peers across Australia’s health and policy community, and spark new conversations shaping the future of metabolic health.
How nutritionists and psychologists collaborate to develop individualised treatment strategies, integrating tailored dietary approaches based on metabolic profiles with psychological interventions addressing behavioural patterns, emotional eating, and sustainable lifestyle change.
Join fellow delegates for a relaxed close to the day — connect with peers from across Australia’s health, research, and policy community, reflect on key takeaways, and continue the conversations shaping the future of obesity and metabolic health.